Daiani Alves Patrícia Assis Tiago Medina New intrinsic- and extrinsic factors of CTLA-4 regulation.
-
Upload
amanda-montgomery -
Category
Documents
-
view
219 -
download
0
Transcript of Daiani Alves Patrícia Assis Tiago Medina New intrinsic- and extrinsic factors of CTLA-4 regulation.
Daiani AlvesPatrícia AssisTiago Medina
New intrinsic- and extrinsic factors of CTLA-4 regulation
CTLA-4 forms generated by splicing
Teff et al., 2006
CTLA-4: a negative regulator of T cell activation
WT CTLA-4-/-
After 4 weeks
Lymphonodes and spleen were removed
Organs weight and number of
lymphocytes were determined
D: ThymusE: SpleenF: MyocardiumG: Lung
CTLA-4-/-
Waterhouse et al., 1995
T-cell fate after TCR engagement
Sharpe & Freeman, 2002
Alegre et al., 2001
Ligand-independent CTLA-4 function
Chikuma & Bluestone, 2003.
StimulationInhibition Stimulation
Inhibition of T cells by CTLA-4 regulation
Egen et al., 2002 Nature immunology
CTLA-4 surface expression and its internalization
Rudd et al., 2009
CTLA-4 inducing prosurvival signaling pathways
Rudd et al., 2009
Cell-intrinsic factors of CLTA-4 regulation
Rudd, 2008
SHP2 LAT and ERK dephosphorylation
PP2A AKT dephosphorylation
CBL-B: E3 ligase (ubiquitylation pathway)
Cell-intrinsic factors of CLTA-4 regulation
Rudd, 2008
↓ TCR ζ‑chain
↓ LAT, SLP76 and GADS adaptors
Inhibition of T-cell raft signaling
Chikuma & Bluestone, 2003.
Could extrinsic-factors also be responsible for CTLA-4 function?
CTLA-4+/+
CTLA-4-/-
Rag2-/- Rag2-/-
WT CTLA-4-/-
Bone marrow adoptivelly transfered
Liver Heart
Backman et al., 1999
Cell-extrinsic factors of CLTA-4 regulation
Rudd, 2008
The reverse stop-signal model for CTLA-4
Rudd, 2008
Daiani Alves
Patrícia Assis
CTLA-4: clinical application
Egen et al., 2002 Nature immunology
Tumor cell
Autoimmune diseases
Shows that hyperproliferative and destructive T cell populations in CTLA-4-deficient mice are not on autopilot but require specific signals
provided by autoantigens to cause tissue damage
Fixing the TCRβ chain prolonged but did not eliminate the disease in Ctla4−/− mice.
DO11.10 TCRβ - β Chain do TCR specific for OVA, presented by the MHC class II molecule and is expressed in 80% to 90% of T cells in the thymus of transgenic animals
Was compared Ctla4−/− mice with Ctla4−/− mice expressing the DO11.10 TCRβ chain (DOβCtla4−/− mice) surviving
4 weeks of age
7 to 10 weeks of age
Examine the characteristics specificity of CD4+ T cells
CD4+ T cells in DOβCtla4−/− mice had an activated surface phenotype
Splenic CD4+ T cells
CYTOMETRY
Naive T CD4+ cells (CD62L) Activated-memory T CD4+ cells (CD44)
DOβCtla4+/+ DOβCtla4+/− DOβCtla4−/− (6-week-old)
Fixation of the TCRβ chain in Ctla4−/− mice did not alter the multiorgan nature of disease in Ctla4−/− mice
Examine the tissue specificity of CD4+ T cells
Normal tissue histology
HistologyHE
DOβCtla4+/+ DOβCtla4+/− DOβCtla4−/− (6-week-old)
Lymphocytic infiltration
Tissue-infiltrating T cells from Ctla4−/− mice are antigen specificity
Pattern of migration and Population expansion
CD4+ T cells (5 × 105 cells)isolated from various tissues
Recipient mice Rag2−/−
DOβCtla4+/+ DOβCtla4+/− DOβCtla4−/−
3 weeks
Splenic CD4+ T cell populations isolated from
DOβCtla4−/− mice, showed expansion in vivo and
migrated into many organs.
T cells isolated from peripheral organs of DOβCtla4−/− mice
accumulated selectively in their organ of origin.
Selective migration of CD4+ T cells isolated from DOβCtla4−/− mice was associated histologically with the induction of tissue pathology
Tissue-infiltrating T cells from DOβCtla4−/− mice cause tissue-specific inflammation
DOβCtla4+/+ DOβCtla4+/– DOβCtla4−/−
Spleen Lungs
Pancreas
CD4+ T cells (5 × 105 cells) purified
Rag2−/−
HISTOLOGY (HE) Spleen
Lungs Pancreas
3 weeks
intense tissue- destructive infiltration
perivascular infiltration and
epithelial changes in the lungs
tissue-destructive lesions of the
exocrine pancreas
To distinguish if the tissue-specific accumulation of DOβCtla4−/− T cells could have been due to either reactivity to tissue-specific antigens or to selective
homing properties ‘imprinted’ after tissue entry
TCRα chains derived from pancreas-infiltrating of Ctla4−/− T cells confer selective pancreatic accumulation.
DOβ Ctla4−/−CD4+ CYTOMETRY
Analysis of lymphoid nonlymphoid tissues
CD4+
minimal pancreatic disease
Infiltating of antigen-specific T cells cause tissue injury in the absence of CTLA-4.
exocrine-specific tissue destruction
To determine if PDIA2 is an autoantigen in Ctla4−/− mice.
Nonobese diabetic mice deficient in the regulator AIRE show immune cell reactivity to pancreatic acinar cells
DOβCtla4−/− mice showed acinar tissue–restricted autoimmunity...
Ctla4+/+Ctla4−/−
T cells (1 × 105 cells) pancreatic lymph nodes
Activated the cells in vitro
PDIA2 (10 µM/ 24 h)+ irradiated splenocytes
(5 × 105 cells)
PDIA2 (protein disulfide isomerase–associated 2), an acinar-specific enzyme
PDIA2 seems to be an authentic autoantigen in Ctla4−/− mice.
ELISA IL-2 Concentrations in
supernatants
20-day-old ELISA anti-PDIA2 titers
Serum
Was examined CD3+ hybridoma cells for TCR reactivity to various antigens
Isolation of PDIA2-specific TCRs from TCRα library.
Hybridomas expressing the TCRα library responded to anti-CD3 but
not OVA
T cell hybridomaCD4+ DOβCtla4−/−
Cultured for 20 h - medium alone
- anti-CD3 (1 µg/ml) -OVA(323–339) (0.3 µM)
+ Irradiated splenocytes.
Induction of GFP
CONTROL
hybridomas expressing the TCRα library reacted
to PDIA2
To enriched PDIA2 reactivity, was isolated these hybridoma populations by sorting GFP+ cells after stimulation with PDIA2
Expression of the 29TCRα chain in the DOβ+ hybridomas regenerated PDIA2-specific reactivity (auto-antigen) in Ctla4−/− mice.
DO11.10 Rag2−/−Ctla4+/+ DO11.10 Rag2−/−Ctla4−/−
Retrovirus infected
29TCRα Thy-1.1
PDIA2-specific Ctla4−/− T cells infiltrate the pancreas.
3 weeks Rag2−/− CD4+ T cells
(1 × 106)
CYTOMETRY Thy-1.1+
Inguinal lymph nodes Pancreatic lymph nodes
Pancreas Lungs
Have the pancreatic accumulation. Infiltration of the pancreas itself was greatly affected by the presence of CTLA-4
To examine how CTLA-4 regulates autoreactive T cells in vivo
The pancreatic infiltration was exocrine specific and
was not present in the heart or lungs
Together these results suggest that CTLA-4 on autoantigen-specific effector T cells diminishes pathogenicity by inhibiting their infiltration into target tissues.
HISTOLOGY (HE)
inguinal lymph nodes pancreatic lymph nodes
pancreas lungs
DO11.10 Rag2−/−Ctla4+/+ DO11.10 Rag2−/−Ctla4−/−
Retrovirus infected
29TCRα Thy-1.1 3 weeks Rag2−/−
CD4+ T cells (1 × 106)
Cell-intrinsic mechanism
Test if CTLA-4 expression by Treg cells is required for their suppressive activity for self antigen–specific T cells
Rag2−/−
Ctla4−/− 29TCRα+ DO11.10 cells
CD4+CD62LhiCD25+ Treg cells(Ctla4+/+ or Ctla4−/−)
CYTOMETRY Thy 1.1+Measured PDIA2-specific T cells
Pancreatic lymph nodes Pancreatic
Cotransfer of Ctla4+/+ Treg cells resulted in the infiltration of significantly fewer PDIA2-specific T cells into the pancreas
Cotransfer of Ctla4+/+ Treg cells prevented the destruction of pancreatic tissue by Ctla4−/− PDIA2-specific T cells
These results demonstrate that autoimmune responses by tissue-specific Ctla4−/− T cells can be regulated by CTLA-4-expressing Treg cells.
Cell-extrinsic mechanism
Conclusion
Set a molecular explanation to CTLA-4 function compatible with a cell-extrinsic mechanism
CTLA-4 could potentially deplete its ligands CD86?
CHO CTLA-4+ CHO CD86-GFP
Flow cytometry
BafA
3h
Confocal Microscopy
CHO CTLA-4+ - Blue
CHO CD86 – Green (GFP)
Time course of CD86 acquisition…
CHO CTLA-4+ CHO CD86-GFP
BafA
It's suggested transfer and degradation of CD86 into CTLA-4+ cells.
C-terminus of CTLA-4 is required for endocytosis?
CHO CTLA-4+
CHO CTLA-4+ del36CHO CD86-GFP
BafA
2h
Confocal MicroscopyFlow cytometry
CD4+ CD25- T cell
Anti-CD35 days
CFSE
By trans-endocytosis, CTLA-4 removes CD86 from neighboring cells, resulting in impaired T cell proliferation
PBMC
CD4+CD25- T cell
Anti-CD3 Confocal Microscopy
CTLA-4 in human CD4+ T cell are also able to capture CD86?
72 h
CD4+CD25- T cellCTLA-4 transfected
CTLA-4 mediated trans-endocytosis was specific to CD80 and CD86
Does TCR stimulation enhances the CD86 acquisition?
PBMC
Dcs SEB pulsed cells
72 hstaphylococcal enterotoxin B
(SEB) SEB CD4+ T cell6 days
Confocal Microscopy
TCR stimulation increased the acquisition of CD86
CD4+ CD25+ T cells (Treg cells) are able to acquire CD86 from APCs?
CD4+CD25- T cellCD4+CD25+ T cell
Anti-CD3 Confocal Microscopy
Flow cytometryPBMC
CD4+CD25+ T cell
Anti-CTLA-4
CFSECD4+CD25- T cell
Depletion of co-stimulatory molecules by CTLA-4 has functional consequences
Rag2-/-
OVA
The removal and degradation of CD80 and CD86 from APCs by CTLA-4 also take place in vivo?
Rag2-/-
Rag2-/-
CD86-GFP OVAchloroquine
Confocal Microscopy6h
DO11.10 T cellDO11.10 T cellCTLA-4 +/+ CTLA-4 -/-
CONCLUSION